Oral mineralocorticoid antagonists for recalcitrant central serous chorioretinopathy

PURPOSE: To evaluate the effect and tolerance of oral mineralocorticoid antagonists, eplerenone and/or spironolactone, in recalcitrant central serous chorioretinopathy. METHODS: Retrospective consecutive observational case series. Primary outcome measures included central macular thickness (CMT, μm)...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Ophthalmol
Main Authors: Chin, Eric K, Almeida, David RP, Roybal, C Nathaniel, Niles, Philip I, Gehrs, Karen M, Sohn, Elliott H, Boldt, H Culver, Russell, Stephen R, Folk, James C
Formato: Artigo
Idioma:Inglês
Publicado em: Dove Medical Press 2015
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4540165/
https://ncbi.nlm.nih.gov/pubmed/26316684
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OPTH.S86778
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados